Jazz Pharmaceuticals JAZZ Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Jazz Pharmaceuticals's net debt?
- Jazz Pharmaceuticals (JAZZ) reported net debt of $4.73B in Q1 2026.
- How has Jazz Pharmaceuticals's net debt changed year-over-year?
- Jazz Pharmaceuticals's net debt increased by 33.6% year-over-year, from $3.54B to $4.73B.
- What is the long-term trend for Jazz Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's net debt has grown at a 31.8% compound annual growth rate (CAGR), from $1.19B to $4.74B.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.